ABCL
AbCellera Biologics Inc. Common Shares
$4.68
8.41%
+0.36
Notify me if price changes either direction
Buy ABCL stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.4B
Enterprise value
891.8M
Trailing PE
-8.4272731434215
Forward PE
-6.0289855
PEG Ratio
-0.71631821719083
Enterprise to EBITDA
-3.833
Enterprise to revenue
25.245
Price to book MRQ
1.2903225
Price to sales TTM
35.250774
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
35.3M
EBITDA
-232664000
Diluted EPS TTM
-0.57
Total Cash (MRQ)
495.7M
Current ratio (MRQ)
10.103
Operating Cash Flow (TTM)
-104552000
ABCL trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
